Disease-modifying drugs for multiple sclerosis in pregnancy: a systematic review.
about
Optimizing the initial choice and timing of therapy in relapsing-remitting multiple sclerosisImmunosuppressive drugs and fertilityPregnancy, sex and hormonal factors in multiple sclerosis.Therapeutic Approach to the Management of Pediatric Demyelinating Disease: Multiple Sclerosis and Acute Disseminated Encephalomyelitis.Multiple sclerosis and pregnancy; What a neurologist may be asked for?A review of safety-related pregnancy data surrounding the oral disease-modifying drugs for multiple sclerosis.Paternal therapy with disease modifying drugs in multiple sclerosis and pregnancy outcomes: a prospective observational multicentric study.Final results from the Betaseron (interferon β-1b) Pregnancy Registry: a prospective observational study of birth defects and pregnancy-related adverse eventsPregnancy in multiple sclerosis: a questionnaire study.Natalizumab in Multiple Sclerosis: Long-Term Management.Risk evaluation and monitoring in multiple sclerosis therapeutics.A systematic review and meta-analysis of strength training in individuals with multiple sclerosis or Parkinson disease.Delayed-Release Dimethyl Fumarate and Pregnancy: Preclinical Studies and Pregnancy Outcomes from Clinical Trials and Postmarketing Experience.Advances in and Algorithms for the Treatment of Relapsing-Remitting Multiple SclerosisRisk-benefit considerations in the treatment of relapsing-remitting multiple sclerosis.Sex and gender issues in multiple sclerosis.Mental toughness, sleep disturbances, and physical activity in patients with multiple sclerosis compared to healthy adolescents and young adultsDisease-Modifying Drug Possibly Linked to Placental Insufficiency: Severe placental complications in a pregnant woman with multiple sclerosis.Pregnancy and the Use of Disease-Modifying Therapies in Patients with Multiple Sclerosis: Benefits versus Risks.What do healthcare providers advise women with multiple sclerosis regarding pregnancy?Interferon β-1a therapy for multiple sclerosis during pregnancy: an unresolved issue.Safety of disease-modifying drugs for multiple sclerosis in pregnancy: current challenges and future considerations for effective pharmacovigilance.Current recommendations for multiple sclerosis treatment in pregnancy and puerperium.Requirement for safety monitoring for approved multiple sclerosis therapies: an overview.Disease modification in multiple sclerosis: an update.Long-term effects of exposure to disease-modifying drugs in the offspring of mothers with multiple sclerosis: a retrospective chart review.A changing treatment landscape for multiple sclerosis: challenges and opportunities.Fertility, pregnancy and childbirth in patients with multiple sclerosis: impact of disease-modifying drugs.Glatiramer acetate: long-term safety and efficacy in relapsing-remitting multiple sclerosis.An overview of pregnancy-related issues in patients with multiple sclerosis.Multiple sclerosis and family planning.Impairment of human neural crest cell migration by prolonged exposure to interferon-beta.Treatment of multiple sclerosis during pregnancy - safety considerations.Optimization and stratification of multiple sclerosis treatment in fast developing economic countries: a perspective from Qatar.Long-term safety evaluation of natalizumab for the treatment of multiple sclerosis.Interferon-beta exposure during first trimester is safe in women with multiple sclerosis-A prospective cohort study from the German Multiple Sclerosis and Pregnancy Registry.Glatiramer acetate during early pregnancy: A prospective cohort study.Natalizumab for the prevention of post-partum relapses in women with multiple sclerosis.[Interferon-β1b in multiple sclerosis therapy: more than 20 years clinical experience].Multiple sclerosis and pregnancy prescriptions.
P2860
Q26777686-0175B447-EED6-4D00-A1A5-CF536DC79970Q26778587-A0D10416-A2D8-43B2-AF8A-F06ADF0723AAQ30354175-47E6791F-06DD-47FF-B89B-240DFC671881Q30354658-71AD8C31-28E6-4FEB-B0FF-A7326AD8809EQ30428993-3A107AAC-FEA7-4A5D-BB71-2F8CC192B04BQ30716854-408E6F0C-E807-415C-957A-9F27576B2280Q31162052-F65C4106-4DB9-4DB7-8699-7643A053E291Q33629433-7C2704E3-E17D-40B4-97B6-FE1B300CE13EQ33717231-9C2F4FDC-68C5-4BAC-96C4-9407C7729F47Q33754882-8984B8F8-4509-48BE-93AB-2244AB9F7D4FQ34513188-3120BFD9-4245-4A60-B20A-D0C8AF37AFEBQ36153283-5E01667D-21B7-4816-9578-54062C87FC09Q36389688-95DE0A63-4445-4789-98E6-35FD8E9677CCQ36484448-9F5B7803-2706-4829-ACE9-0D5DCF87EDF4Q36975701-4DF3014A-5E4D-441C-9DA9-6C22CF0A127AQ36999743-3F675BCD-E13A-4B2D-B92D-D8C717DED976Q37058811-B17749DA-EC64-4CE3-A7D9-D5A9BF142CF7Q37200641-EAEFB95A-1370-4B2F-90DA-C45922DF8BFEQ37547683-A1259525-85F6-415D-9942-84F99A88988FQ37661566-3A64F7E6-9FCD-471E-871E-00C58F2A2305Q37703741-C61B26FC-8082-4786-8EAB-FEAE8B5B5C9EQ38085336-0F3C41D0-8E54-45A6-93CE-3A8D68B025AFQ38125249-F081DF07-D409-4AB7-A927-2FC3BEF81AF5Q38150405-02802985-9E2E-4519-A502-A43B6066C4E3Q38150823-C4151A9B-D3D7-4A81-B567-10C07D209E9FQ38151555-F041729D-F190-4BA4-9847-E8C63FD0044AQ38180166-B6841827-4851-4847-8B05-99C10C52197CQ38379249-7F1BE031-E06A-4B01-B4FB-BDD0FBBFC63CQ38449394-B15AD081-7252-412F-BB28-89B4B53E3F89Q38587675-1E2B13BD-F883-4EC7-B0D8-BC1413522CFBQ38649287-473A6459-8D81-4AEF-9716-4F425427213CQ38862416-358154F8-97C3-46CB-ABB6-5910E9684991Q38883520-427E107B-7F11-4293-B787-824B02CC3553Q39021942-8C76EE85-00E6-4544-94ED-522A4B841A8BQ39391443-6692A231-8021-4F34-AB08-18186DCED7E5Q39964998-D7FE6B1F-9643-46EA-9838-8E92005800A7Q40120131-C746DCBA-D8EE-4BAE-AEAF-1C7A5BAE3CA3Q44106109-DF7E3DA3-701A-465E-AE28-60719C785645Q45155454-2806E34D-9BFA-4032-8A02-8E3E730F4386Q45796699-9F19E2FD-0B16-4C11-9C20-9D31BE624FA7
P2860
Disease-modifying drugs for multiple sclerosis in pregnancy: a systematic review.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Disease-modifying drugs for multiple sclerosis in pregnancy: a systematic review.
@ast
Disease-modifying drugs for multiple sclerosis in pregnancy: a systematic review.
@en
type
label
Disease-modifying drugs for multiple sclerosis in pregnancy: a systematic review.
@ast
Disease-modifying drugs for multiple sclerosis in pregnancy: a systematic review.
@en
prefLabel
Disease-modifying drugs for multiple sclerosis in pregnancy: a systematic review.
@ast
Disease-modifying drugs for multiple sclerosis in pregnancy: a systematic review.
@en
P2093
P2860
P1433
P1476
Disease-modifying drugs for multiple sclerosis in pregnancy: a systematic review.
@en
P2093
Anne Synnes
Bing Wei Wang
Colleen Guimond
Dessa Sadovnick
P2860
P304
P356
10.1212/WNL.0B013E3182698C64
P407
P577
2012-08-29T00:00:00Z